Feng Chi Biotech Corp. (TPEX:6744)

Feng Chi Biotech Revenue

Feng Chi Biotech had revenue of 75.67M TWD in the half year ending June 30, 2026, a decrease of -13.22%. This brings the company's revenue in the last twelve months to 156.99M, down -12.75% year-over-year. In the year 2025, Feng Chi Biotech had annual revenue of 177.36M with 3.66% growth.

• Revenue (ttm): 156.99M
• Revenue Growth: -12.75%
• P/S Ratio: 1.52
• Revenue / Employee: n/a
• Employees: 32
• Market Cap: 238.70M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	177.36M	6.26M	3.66%
Dec 31, 2024	171.10M	-9.48M	-5.25%
Dec 31, 2023	180.58M	-12.88M	-6.66%
Dec 31, 2022	193.46M	10.89M	5.96%
Dec 31, 2021	182.57M	3.66M	2.05%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 12, 2026

Data Sources Report a data error